{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:49:47Z","timestamp":1789397387085,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.bmcl.2020.127515","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T22:05:15Z","timestamp":1598479515000},"page":"127515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Progress towards a stable cephalosporin-halogenated phenazine conjugate for antibacterial prodrug applications"],"prefix":"10.1016","volume":"30","author":[{"given":"Tao","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3811-2721","authenticated-orcid":false,"suffix":"III","given":"Robert W.","family":"Huigens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2020.127515_b0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cell.2020.02.056","article-title":"The science of antibiotic discovery","volume":"181","author":"Lewis","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2020.127515_b0010","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.1021\/acs.jmedchem.9b00370","article-title":"Recent progress in natural-product-inspired programs aimed at addressing antibiotic resistance and tolerance","volume":"62","author":"Abouelhassan","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127515_b0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41429-020-0291-8","article-title":"Antibiotics in the clinical pipeline in October 2019","volume":"73","author":"Butler","year":"2020","journal-title":"J Antibiot"},{"key":"10.1016\/j.bmcl.2020.127515_b0020","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S1473-3099(20)30178-X","article-title":"Real-world antibiotic needs for resistant Gram-negative infections","volume":"20","author":"Fitzpatrick","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmcl.2020.127515_b0025","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of antibiotic resistance","volume":"4","author":"Munita","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.bmcl.2020.127515_b0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1039\/C5MD00394F","article-title":"Endless resistance. Endless antibiotics?","volume":"7","author":"Fisher","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.bmcl.2020.127515_b0035","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature17042","article-title":"Antibacterial drug discovery in the resistance era","volume":"529","author":"Brown","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2020.127515_b0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/472032a","article-title":"Fix the antibiotics pipeline","volume":"472","author":"Cooper","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2020.127515_b0045","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1021\/acsinfecdis.9b00413","article-title":"Instructive advances in chemical microbiology inspired by nature\u2019s diverse inventory of molecules","volume":"6","author":"Liu","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmcl.2020.127515_b0050","series-title":"Antibiotics: Challenges, Mechanisms","author":"Walsh","year":"2016"},{"key":"10.1016\/j.bmcl.2020.127515_b0055","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1039\/C3OB42416B","article-title":"Phenazine antibiotic inspired discovery of potent bromophenazine antibacterial agents against Staphylococcus aureus and Staphylococcus epidermidis","volume":"12","author":"Borrero","year":"2014","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmcl.2020.127515_b0060","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1039\/C4RA08728C","article-title":"Bromophenazine derivatives with potent inhibition, dispersion and eradication activities against Staphylococcus aureus biofilms","volume":"5","author":"Garrison","year":"2015","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmcl.2020.127515_b0065","doi-asserted-by":"crossref","first-page":"14819","DOI":"10.1002\/anie.201508155","article-title":"Halogenated phenazines that potently eradicate biofilms, MRSA persister cells in non-biofilm cultures and Mycobacterium tuberculosis","volume":"54","author":"Garrison","year":"2015","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2020.127515_b0070","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1021\/acs.jmedchem.5b02004","article-title":"Structure-activity relationships of a diverse class of halogenated phenazines that targets persistent, antibiotic-tolerant bacterial biofilms and Mycobacterium tuberculosis","volume":"59","author":"Garrison","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127515_b0075","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41598-017-01045-3","article-title":"A highly potent class of halogenated phenazine antibacterial and biofilm-eradicating agents accessed through a modular Wohl-Aue synthesis","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2020.127515_b0080","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1021\/acs.jmedchem.7b01903","article-title":"An efficient Buchwald-Hartwig\/reductive cyclization for the scaffold diversification of halogenated phenazines: Potent antibacterial targeting, biofilm eradication and prodrug exploration","volume":"61","author":"Garrison","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127515_b0085","doi-asserted-by":"crossref","first-page":"15523","DOI":"10.1002\/anie.201809785","article-title":"Transcript profiling of MRSA biofilms treated with a halogenated phenazine eradicating agent: A platform for defining cellular targets and pathways critical to biofilm survival","volume":"57","author":"Abouelhassan","year":"2018","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2020.127515_b0090","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1002\/cbic.201900116","article-title":"Phenazine antibiotic-inspired discovery of bacterial biofilm-eradicating agents","volume":"20","author":"Huigens","year":"2019","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bmcl.2020.127515_b0095","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1021\/acs.jmedchem.8b00218","article-title":"A synthetic dual drug sideromycin induces Gram-negative bacteria to commit suicide with a Gram-positive antibiotic","volume":"61","author":"Liu","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127515_b0100","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1002\/anie.201202414","article-title":"Cephalosporin-3'-diazeniumdiolates: Targeted NO-donor prodrugs for dispersing bacterial biofilms","volume":"51","author":"Barraud","year":"2012","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2020.127515_b0105","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1039\/c2ra01351g","article-title":"\u03b2-Lactam-host defence peptide conjugates as antibiotic prodrug candidates targeting resistant bacteria","volume":"2","author":"Desgranges","year":"2012","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmcl.2020.127515_b0110","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.bmcl.2008.12.057","article-title":"Design and synthesis of a \u03b2-lactamase activated 5-fluorouracil prodrug","volume":"19","author":"Phelan","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2020.127515_b0115","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/molecules13040841","article-title":"Synthesis and total 1H- and 13C-NMR assignment of cephem derivatives for use in ADEPT approaches","volume":"13","author":"Blau","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2020.127515_b0120","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0960-894X(03)00242-7","article-title":"Synthesis of beta-lactamase activated nitric oxide donors","volume":"13","author":"Tang","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2020.127515_b0125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0223-5234(01)01331-9","article-title":"Synthesis and antibacterial activity of dual-action agents of a \u03b2-lactam antibiotic with cytotoxic agent mitozolomide or temozolomide","volume":"37","author":"Wang","year":"2002","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127515_b0130","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1016\/S0040-4020(00)00419-1","article-title":"\u03b2-Lactamase-dependent prodrugs\u2014recent developments","volume":"56","author":"Smyth","year":"2000","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmcl.2020.127515_b0135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3987\/COM-92-S22","article-title":"Synthesis of a cephalosporin-doxorubicin antitumor prodrug: a substrate for an antibody-targeted enzyme","volume":"35","author":"Jungheim","year":"1993","journal-title":"Heterocycles"},{"issue":"Suppl. 3","key":"10.1016\/j.bmcl.2020.127515_b0140","first-page":"659","article-title":"Synthesis and in vitro antibacterial activity of some novel cephem antibiotics","volume":"4","author":"Gaurav","year":"2012","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.bmcl.2020.127515_b0145","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ajoc.201300108","article-title":"2-Nitrobenzyl esters of penam and cephem derivatives as inhibitors of penicillin-binding proteins","volume":"2","author":"Brul\u00e9","year":"2013","journal-title":"Asian J Org Chem"},{"key":"10.1016\/j.bmcl.2020.127515_b0150","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1080\/00397919608003727","article-title":"A simple preparative method for tert-butyl protection of aminocephalosporanic acid","volume":"26","author":"Grigan","year":"1996","journal-title":"Synth Commun"},{"key":"10.1016\/j.bmcl.2020.127515_b0155","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1021\/jm00171a028","article-title":"Inhibition of human leukocyte elastase. 1. Inhibition by C-7-substituted cetphalosporin tert-butyl esters","volume":"33","author":"Doherty","year":"1990","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127515_b0160","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/1099-0690(200107)2001:13<2529::AID-EJOC2529>3.0.CO;2-9","article-title":"A new convenient synthesis of 3-carboxycephems starting from 7-aminocephalosporanic acid (7-ACA)","author":"Keltjens","year":"2001","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.bmcl.2020.127515_b0165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ab.2015.06.032","article-title":"Assay for drug discovery: Synthesis and testing of nitrocefin analogues for use as \u03b2-lactamase substrates","volume":"486","author":"Ghavami","year":"2015","journal-title":"Anal Biochem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20306260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20306260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:38:35Z","timestamp":1760773115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X20306260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":33,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0960894X20306260"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127515","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress towards a stable cephalosporin-halogenated phenazine conjugate for antibacterial prodrug applications","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"127515"}}